Share Twitter LinkedIn Facebook Email Thomas Powles, MD, MBBS @tompowles1 of @QMBCI answers common questions regarding the JAVELIN study including what happens to patients with progression of disease?
Podcast Sumanta Pal, MD @montypal @cityofhope @cityofhopeoc #ASCO22 #OncoTwitter Results from Cohorts 3, 4, 5 of the COSMIC-021 Study Urology 3 Mins Read
Sumanta Pal, MD @montypal @cityofhope @cityofhopeoc #ASCO22 #OncoTwitter Results from Cohorts 3, 4, 5 of the COSMIC-021 Study Urology 3 Mins Read
Petros Grivas, MD, PhD @SeattleCCA #UrothelialCancer FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carci… Urology 2 Mins Read
